Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Chemomab Therapeutics Ltd. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 10 | 14 | +4 |
| Shares | 390.3K | 367.4K | −22.9K (−5.9%) |
| Value | $1.03M | $606.1K | −$420.4K (−41.0%) |
New holders (6)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 103,781 | $171.2K | 0.00% |
| ADAR1 Capital Management, LLC | 80,000 | $132.0K | 0.01% |
| Kestra Private Wealth Services, LLC | 51,710 | $85.3K | 0.00% |
| XTX Topco Ltd | 19,013 | $31.4K | 0.00% |
| Virtu Financial LLC | 10,933 | $18.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 2 | $3 | 0.00% |
Sold out (2)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Sphera Funds Management Ltd. | 179,425 | $471.9K |
| Stonepine Capital Management, LLC | 30,000 | $78.9K |